Skip to main content

Ikarian Capital, LLC

Position in OLMA — Olema Pharmaceuticals, Inc.

CIK 1778253 DALLAS, TX

Position in OLMA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$4,794,845
-$4,125,524 QoQ
Shares Held
383,281
-35.9% QoQ
Ownership
0.438%
of shares outstanding
% of Portfolio
0.78%
of 13F equity value
Holder Rank
#42
of 182 holders
Holding Since
Sep 2024
6 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in OLMA Over Time

Shares Held

Position Value (USD)

Derivatives in OLMA

reported options exposure · as of Jun 30, 2026
CallValue
$2,502,000
CallShares
200,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Ikarian Capital, LLC holds $559,861,982 across 103 Biotechnology names. OLMA ranks #39 (0.9% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in OLMA

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,502,000 200,000
2026-06-30 $4,794,845 383,281
2026-03-31 $8,197,518 549,800
2026-03-31 $8,920,369 598,281
2025-12-31 $18,966,350 758,654
2025-12-31 $5,000,000 200,000
2025-03-31 $721,897 191,994
2024-12-31 $536,325 91,994
2024-09-30 $1,098,480 92,000